K. Eger

1.1k total citations
19 papers, 464 citations indexed

About

K. Eger is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, K. Eger has authored 19 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 5 papers in Neurology. Recurrent topics in K. Eger's work include Muscle Physiology and Disorders (6 papers), Inflammatory Myopathies and Dermatomyositis (5 papers) and Mitochondrial Function and Pathology (4 papers). K. Eger is often cited by papers focused on Muscle Physiology and Disorders (6 papers), Inflammatory Myopathies and Dermatomyositis (5 papers) and Mitochondrial Function and Pathology (4 papers). K. Eger collaborates with scholars based in Germany, United States and Austria. K. Eger's co-authors include Stephan Zierz, Berit Jordan, S. Zierz, Marcus Deschauer, Max J. Hilz, N. Strigl‐Pill, Carsten Wessig, Matthias Spranger, Benedikt Schoser and Karlheinz Reiners and has published in prestigious journals such as Journal of Neurology, Journal of Inherited Metabolic Disease and Neuromuscular Disorders.

In The Last Decade

K. Eger

17 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Eger Germany 9 226 206 156 127 84 19 464
Nicolai Preisler Denmark 18 239 1.1× 287 1.4× 280 1.8× 83 0.7× 83 1.0× 30 645
J.H.J. Wokke Netherlands 7 303 1.3× 240 1.2× 98 0.6× 195 1.5× 86 1.0× 15 530
Claudio Semplicini Italy 17 214 0.9× 185 0.9× 238 1.5× 38 0.3× 64 0.8× 25 480
Robert‐Yves Carlier France 12 135 0.6× 155 0.8× 253 1.6× 68 0.5× 103 1.2× 37 546
N. Strigl‐Pill Germany 6 361 1.6× 309 1.5× 65 0.4× 99 0.8× 31 0.4× 7 456
Pascal Laforêt France 9 133 0.6× 118 0.6× 178 1.1× 41 0.3× 36 0.4× 18 367
C. Iturriaga Spain 8 195 0.9× 49 0.2× 188 1.2× 24 0.2× 65 0.8× 8 464
Ziad Rifai United States 8 79 0.3× 97 0.5× 232 1.5× 55 0.4× 66 0.8× 9 361
Stephanie DeArmey United States 14 467 2.1× 319 1.5× 99 0.6× 48 0.4× 12 0.1× 19 573
Carine I. van Capelle Netherlands 14 490 2.2× 408 2.0× 69 0.4× 61 0.5× 12 0.1× 18 600

Countries citing papers authored by K. Eger

Since Specialization
Citations

This map shows the geographic impact of K. Eger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Eger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Eger more than expected).

Fields of papers citing papers by K. Eger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Eger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Eger. The network helps show where K. Eger may publish in the future.

Co-authorship network of co-authors of K. Eger

This figure shows the co-authorship network connecting the top 25 collaborators of K. Eger. A scholar is included among the top collaborators of K. Eger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Eger. K. Eger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Zierz, Stephan, Marcus Deschauer, K. Eger, et al.. (2014). Muskelerkrankungen.
2.
Jordan, Berit, et al.. (2010). Camptocormia phenotype of FSHD: a clinical and MRI study on six patients. Journal of Neurology. 258(5). 866–873. 40 indexed citations
3.
Kraya, Torsten, et al.. (2010). Genotypes and Phenotypes of distal myopathy. Klinische Neurophysiologie. 41(1). 1 indexed citations
4.
Jordan, Berit, K. Eger, & S. Zierz. (2009). Thymomassoziierte Polymyositis. Der Nervenarzt. 80(6). 708–711. 6 indexed citations
5.
Eger, K., et al.. (2009). Beevor’s sign in facioscapulohumeral muscular dystrophy: an old sign with new implications. Journal of Neurology. 257(3). 436–438. 29 indexed citations
6.
Strigl‐Pill, N., Cornelia Kornblum, K. Eger, et al.. (2009). Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial. Journal of Neurology. 257(1). 91–97. 196 indexed citations
7.
Fernández‐Santiago, Rubén, Peter Lichtner, Anne‐Dorte Sperfeld, et al.. (2009). Identification of novel Angiogenin (ANG) gene missense variants in German patients with amyotrophic lateral sclerosis. Journal of Neurology. 256(8). 1337–1342. 51 indexed citations
8.
Gläser, Dieter, Susanne M. Schmidt, Matthias Vorgerd, et al.. (2008). Molecular diagnosis of German patients with late‐onset glycogen storage disease type II. Journal of Inherited Metabolic Disease. 31(S2). 261–265. 33 indexed citations
9.
Jordan, Berit, K. Eger, Marcus Deschauer, & S. Zierz. (2007). G.P.10.05 Successful long-term treatment of MuSK antibody-positive myasthenia gravis with rituximab, a follow up. Neuromuscular Disorders. 17(9-10). 819–819. 1 indexed citations
10.
Hanisch, F., et al.. (2006). Lactate production upon short-term non–ischemic forearm exercise in mitochondrial disorders and other myopathies. Journal of Neurology. 253(6). 735–740. 7 indexed citations
11.
Krasnianski, Michael, et al.. (2003). Fazioskapulohumerale Muskeldystrophie. Der Nervenarzt. 74(2). 151–158. 4 indexed citations
12.
Krasnianski, Michael, K. Eger, Stephan Neudecker, Sibylle Jakubiczka, & Stephan Zierz. (2003). Atypical Phenotypes in Patients With Facioscapulohumeral Muscular Dystrophy 4q35 Deletion. Archives of Neurology. 60(10). 1421–1421. 40 indexed citations
13.
Krasnianski, Michael, Stephan Neudecker, K. Eger, Sibylle Jakubiczka, & Stephan Zierz. (2003). Typical facioscapulohumeraldystrophy phenotype in patients without FSHD 4q35deletion. Journal of Neurology. 250(9). 1084–1087. 4 indexed citations
14.
Eger, K. & S. Zierz. (2001). Limb-girdle muscular dystrophy. DMW - Deutsche Medizinische Wochenschrift. 126(22). 655–658.
15.
Wieser, Thomas, Dominikus Bönsch, K. Eger, Wilhelm Schulte‐Mattler, & S. Zierz. (2000). A family with PROMM not linked to the recently mapped PROMM locus DM2. Neuromuscular Disorders. 10(2). 141–143. 10 indexed citations
16.
Cohen, José E., K. Eger, Antonio Montero, & Zvi Israel. (1998). Rapid spontaneous resolution of acute subdural hematoma and HIV related cerebral atrophy: case report. Surgical Neurology. 50(3). 241–244. 27 indexed citations
17.
Eger, K., Wilhelm Schulte‐Mattler, & S. Zierz. (1997). Proximale myotone Myopathie (PROMM)Klinische Variabilität innerhalb einer Familie. Der Nervenarzt. 68(10). 839–844. 5 indexed citations
18.
Schulte‐Mattler, Wilhelm, S. Zierz, & K. Eger. (1997). Proximale myotone Myopathie (PROMM). Der Nervenarzt. 68(10). 839–844. 9 indexed citations
19.
Eger, K., et al.. (1967). [Preventive and curative silicotropic effect of polyvinylpyridine-N-oxide in liver and spleen tests].. PubMed. 93. 15–32. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026